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Abstract
Prader-Willi syndrome (PWS) is a rare neurodevelopmental genetic disorder associated with a characteristic
behavioral phenotype that includes severe hyperphagia and a variety of other behavioral challenges such as
temper outbursts and anxiety. These behaviors have a significant and dramatic impact on the daily functioning and
quality of life for the person with PWS and their families. To date, effective therapies addressing these behavioral
challenges have proven elusive, but several potential treatments are on the horizon. However, a limiting factor for
treatment studies in PWS is the lack of consensus in the field regarding how to best define and measure the
complex and interrelated behavioral features of this syndrome. The International PWS Clinical Trials Consortium
(PWS-CTC, www.pwsctc.org) includes expert PWS scientists, clinicians, and patient advocacy organization
representatives focused on facilitating clinical trials in this rare disease. To address the above gap in the field,
members of the PWS-CTC “Behavior Outcomes Working Group” sought to develop a unified understanding of the
key behavioral features in PWS and build a consensus regarding their definition and description. The primary focus
of this paper is to present consensus definitions and descriptions of key phenotypic PWS behaviors including
hyperphagia, temper outbursts, anxiety, obsessive–compulsive behaviors, rigidity, and social cognition deficits.
Patient vignettes are provided to illustrate the interrelatedness and impact of these behaviors. We also review some
available assessment tools as well as new instruments in development which may be useful in measuring these
behavioral features in PWS.
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Background
Prader-Willi syndrome (PWS) is a rare genetic neurode-
velopmental disorder that occurs in approximately 1 in
15,000 to 30,000 births, caused by a loss of paternally
expressed imprinted genes on chromosome 15q11.2–
q13 [1]. Genetic subtypes of PWS include paternal
deletion (del) of the 15q11.2-13 region, which occurs in
approximately 65% of individuals; maternal uniparental
disomy (UPD), which occurs in ~30%; and less com-
monly, an imprinting center defect diagnosed in 3–5%
of cases [2]. PWS affects multiple systems, with clinical
features that include hypotonia, growth hormone
deficiency, hypogonadotropic hypogonadism, sleep distur-
bances, reduced pain sensitivity, decreased gastrointestinal
motility, and scoliosis. A defining feature of PWS, which is
rare among neurodevelopmental disorders, is the signifi-
cant change in eating behavior over time. Whereas infants
with PWS have difficulty feeding and may exhibit failure
to thrive, a persistent and unregulated desire to eat
(hyperphagia) develops during childhood. Unless access to
food is strictly controlled, an overwhelming drive to eat
coupled with decreased energy expenditure in individuals
with PWS leads to morbid obesity. The physiological basis
of hyperphagia in PWS remains unclear, and currently,
there are no approved medications that effectively treat
hyperphagia or other symptoms commonly seen in
the syndrome. However, clinical trials testing the
effectiveness of novel agents against hyperphagia and
related PWS symptoms are currently underway or
recently completed [3–11].
In addition to hyperphagia, other behavioral challenges
also prominent in PWS include temper outbursts, anx-
iety, obsessive–compulsive behaviors, rigidity, and social
skills (Table 1) [12–18]. These behaviors may or may
not be food related. In addition, as individuals with PWS
reach adulthood, they are also at high risk for developing
psychiatric illness, including psychosis, anxiety disorders,
and major depression [19]. The PWS neuropsychiatric
phenotype is further complicated by impaired cognition,
including intellectual disability, academic difficulties, and
specific deficits in social cognition such as perspective
taking and reading social/emotional cues [20–22].
Although some clinical trials and intervention studies
are occurring, there are distinct challenges to conducting
studies in PWS due to the complex interrelated behav-
ioral features. One limitation for the field is the lack of
consensus on how to best define or measure many of
the complex behaviors associated with PWS. PWS-CTC
“Behavior Outcomes Working Group” includes PWS
scientists, clinicians, and patient advocacy organization
representatives with expertise in the behavioral aspects
of PWS. This group sought to address the lack of con-
sensus definitions and descriptions of PWS-associated
behavioral features. Using literature review, clinical pa-
tient experience, and parent focus groups, the Working
Group developed a unified understanding of the key be-
havioral features in PWS which is presented here. Devel-
oping a consensus understanding of the behavioral
manifestations in PWS provides an important founda-
tion upon which treatment studies targeting those be-
haviors can be developed and pursued.
Hyperphagia in PWS
Definition
Hyperphagia in PWS manifests as an intense persistent
sensation of hunger accompanied by food preoccupa-
tions, an extreme drive to consume food, food-related
behavior problems, and a lack of normal satiety. Hyper-
phagia falls at the far end of a continuum of overeating
behaviors and is considered the most extreme form of
overeating [23].
Description
A complex progression characterizes the development of
hyperphagia, a hallmark feature of PWS [24]. Infants
with PWS present with hypotonia, excessive sleepiness,
decreased activity, poor suck, and may show little inter-
est in food. This stage is typically followed by a period of
relatively normal growth and weight gain. Subsequently,
young children with PWS begin to gain weight easily
and show an increasingly strong interest in food. Most
individuals go on to develop hyperphagia marked by a
lack of normal satiety and an overwhelming drive to eat.
The onset of hyperphagia is variable and can occur in
early childhood, but the average age of onset is 8 years
old [24, 25]. This strong drive to consume food is likely
underpinned by persistent feelings of hunger with sati-
ation only developing after excessive calorie intake. Even
then, satiety does not persist for any length of time com-
pared to a control group without PWS [26]. Individuals
Table 1 PWS behavioral features definitions
Hyperphagia: intense persistent sensation of hunger accompanied by
food preoccupations, an extreme drive to consume food, food-related
behavior problems, and a lack of normal satiety
Temper outbursts: highly explosive episodes in which the person with
PWS becomes very angry or upset in a way that seems excessive for the
situation and also beyond the person’s control
Anxiety: excessive worry and tension often related to schedules/
routines, food planning or food security, persons/items of special
interest and excessive concerns about the possibility of change
Obsessive compulsive behaviors: repetitive, ritualistic behaviors,
collecting and hoarding items, insistence on “sameness,” need to know,
ask, or tell
Rigidity: ardent inflexibility with certain routines, concepts, or ways of
thinking; vigorous resistance to change; black and white thinking
Social cognition: difficulties relating to others, challenges with
reciprocal social communication, recognizing others’ emotions, empathy
and accurate interpretation of social cues.
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with PWS can readily consume up to three times the
normal caloric intake at a given meal, may hoard food,
and may eat discarded food [26, 27]. The lack of normal
satiety is notable, as exemplified by reported cases of
gastric necrosis or stomach rupture arising from extreme
overeating [28, 29]. Hyperphagia is life-long in most
individuals with PWS, but eating and food interest can
wax and wane over time, especially in response to
changes in the environment, such as changes in food
security or alterations of the food schedule. In general,
no consistent differences in hyperphagia have been
found between gender or PWS genetic subtypes [30].
However, one small study found that food-related behav-
iors were more severe in PWS males with deletion [31].
Overall, the severity of hyperphagia is not necessarily
correlated with degree of obesity in PWS; access to food
is typically the biggest determinant of weight.
PWS-associated hyperphagia has overlap with several
other conditions, including binge eating disorder,
addiction, and obsessive-compulsive features (preoccupa-
tion with food) [32, 33]. However, it is distinguished from
these conditions by its presence in early childhood as well
as physiological studies suggesting that the hyperphagia in
PWS likely is related to a pathological defect of satiety [26,
34–36]. Additionally, a recent study indicated that individ-
uals with PWS display abnormal patterns of neural activity
in response to food representations [37].
For families and caregivers, PWS-related hyperphagia
is incessant in that once hyperphagia starts, individuals
with PWS are constantly in search of food. Thus, for the
safety of the person with PWS, restricting access to food
and controlling food intake “food security” are para-
mount and a 24/7 concern for families. Food security
may include restricting access to food with locks on re-
frigerators and pantries, keeping food out of sight and
constant supervision, i.e., “eyes on” the person with PWS
at all times to ensure they are not seeking/eating food
they should not be consuming. This food security must
be implemented across all settings, i.e., home, school,
work, and social; families must educate all who interact
with the person with PWS. Food security also includes
schedules and plans for all meals and food consumption.
Changes to those plans can lead to significant behavioral
challenges for the person with PWS. Families, caregivers,
and clinicians have described hyperphagia in PWS as an
overwhelming, life-threatening force, which sentences
people with PWS to a lifetime of environmental control
and restricted lifestyle [23, 38]. Treating hyperphagia is
the highest priority for caregivers [39].
Observable behaviors
Hyperphagic behaviors in PWS include intense focus on
food, which can manifest as excessive talking/asking
about food, especially details regarding what and when
they will eat, and persistently searching for food. The
drive to eat can lead to food sneaking/food theft, eating
food left on other people’s plates, eating food that is nor-
mally considered unacceptable (e.g., food scraps, food in
the trash, raw food) or non-food items (e.g., dirt, grass,
soap), getting up at night to look for food, taking very
large bites of food, and eating very fast [40]. Additional
behaviors include becoming agitated or anxious in the
presence of food, bargaining for more food, trying to de-
ceive others or lying to obtain food, becoming upset or
exhibiting temper outbursts when food is denied, and
becoming aggressive to obtain food.
Assessment of the behavior
The assessment of hyperphagia in the typical population
has employed food diaries, visual scales, and test meals
in research settings [41]. These methods are considered
not useful in PWS due to the individual with PWS’s
reluctance to report on their food intake related to
concerns about “getting in trouble” and worries about
dietary repercussions [42, 43]. Self-report of degree of
hunger in individuals with PWS may also be limited
by cognitive and communication challenges [44]. In
addition, many people with PWS are on calorie-
restricted diets; thus, food diaries would not accurately
reflect their hunger or hyperphagia. Finally, there are
ethical problems of test meals [23] in PWS. And given
the physiological impairments in satiety mechanisms
in PWS, individuals may not fully experience the con-
trast between hunger and satiety. Thus, PWS patient-
reported hunger scales are considered to be unreliable
in this population.
Given the challenges of self-reporting in this popu-
lation, the field has focused on the use of observer
(i.e., caregiver) reported assessment of hyperphagia in
PWS. The most frequently used measure of hyperpha-
gia in PWS is the Hyperphagia Questionnaire for
Clinical Trials (HQ-CT) [45]. The HQ-CT is a 9-item
scale that assesses the severity of specific hyperphagic
behaviors including food seeking and food-related
preoccupations by assessing distress and adaptive im-
pairment related to hyperphagia. This instrument is
modified from a questionnaire developed specifically
to quantify hyperphagia in PWS [42], and adapted for
use in clinical trials [45]. This observer-reported out-
come measure, which aims to measure more objective
food-related behavior, is based on behaviors over the
past 2 weeks reported by a caregiver who is familiar
with the daily activities of the person with PWS.
Beyond self- or observer-reported assessment of
hyperphagia in PWS, there is interest in the field for
developing assessment tools that employ objective,
direct measures of food interest, such as eye gaze or
evoked response potentials [46, 47].
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Temper outbursts in PWS
Definition
Temper outbursts in PWS are defined as highly emo-
tional or explosive episodes in which the person with
PWS becomes “very angry or upset in a way that seems
excessive for the situation and also beyond the person’s
control” [48].
Description
Temper outbursts, sometimes described as emotional
outbursts, “tantrums,” or “meltdowns,” are one of the
most common maladaptive behaviors reported by
parents of children, adolescents, and adults with PWS
[5, 6, 37], with a significant impact on quality of life, in
some instances equal to or greater than hyperphagia. A
small study of PWS families showed a high percentage
of siblings experienced PTSD symptoms, and families
reported lower overall quality of life compared with
normative samples [49]. Additionally, for the individual
with PWS, temper outbursts often result in reduced op-
portunities to socialize in the community, limit living
options, and undermine employment. Approximately
80% of individuals with PWS exhibit severe temper out-
bursts beginning in childhood and persisting throughout
adult life [50]. There may be some decrease in frequency
of outbursts in adults compared to children with PWS,
but adolescents and adults often have outbursts of lon-
ger duration than children with PWS [48]. There are no
consistent differences in the characteristics of temper
outbursts across genders or PWS genetic subtypes [48].
The sequence of behaviors and emotions within tem-
per outbursts in PWS are similar to those seen in typic-
ally developing young children, yet the onset begins
slightly later in life, and they continue throughout adult-
hood [48]. These outbursts may be related to “arrested
emotional development” in PWS as well to the conflu-
ence of hyperphagia, diminished coping skills, poor emo-
tional control/regulation, and limited executive function
skills [51–54]. Triggers for temper outbursts in PWS
generally fall into the following categories: blocking of a
desired goal, a violation of social expectations, perceived
injustice, or difficulty dealing with a change in routine
[48, 54, 55]. It has been hypothesized that PWS out-
bursts might be related to hyperphagia. However, Rice
et al. [48] found that most parents of young children
with PWS reported temper outbursts occurring before
the onset of hyperphagia, suggesting outbursts may be
developing independent of hyperphagia. One possible
mechanism driving the temper outbursts triggered by
changes in routine may be a deficit in task-switching
ability, a cognitive-related executive function that is an
area of particular difficulty in individuals with PWS [56,
57]. Dysregulation of the autonomic nervous system may
be another key mechanism underlying temper outbursts
in PWS. A small pilot study [58] indicated that stimula-
tion of the vagus nerve decreased temper outbursts for
some individuals with PWS, suggesting the role of the
autonomic nervous system in this behavioral feature.
Observable behaviors
Temper outbursts often manifest with the following
behaviors: repetitive questioning that may escalate in
volume, angry facial expression, increased salivation,
talking very loudly, crying, yelling, stomping the feet,
slamming doors, kicking, hitting, laying on the ground,
and throwing objects/destroying things. Temper out-
bursts often follow a particular sequence of behaviors
starting with emotional behaviors, such as crying and
emotional vocalizations. This is rapidly followed by
rising anger and more overt behaviors such as verbal
and sometimes physical aggression. Early on, it may be
possible to distract the individual and avert the full out-
burst, but there is a point at which the person is unable
to bring themselves under control. Temper outbursts
may last from minutes to hours before resolving, and
there is often a distinct period of “tuning out” or shut
down after an outburst and a need for sleep. The
sequence may often end with expressions of regret and
distress [54].
Assessment of the behavior
Currently, there are no measures that are validated
specifically for the assessment of temper outbursts in
PWS; however, several measures have been developed to
assess severe behavior challenges in individuals with in-
tellectual disability, which may be applicable to assessing
temper outbursts in PWS studies. Among these, the
Developmental Behavior Checklist–Monitoring Version
(DBC-M) is a caregiver-reported daily diary using items
from the Developmental Behavior Checklist [59]. It has
been used in a previous clinical trial examining the
potential utility of oxytocin for treating behavioral
challenges in PWS [53]. Alternatively, the Challenging
Behavior Interview has shown utility in a small study
assessing the impact of vagus nerve stimulation on tem-
per outbursts in PWS [58]. Finally, the Aberrant Behav-
ior Checklist (ABC-2 [60]; irritability scale) which has
been used widely in studies on those with intellectual
disability may provide a useful validated measure of
temper outbursts in PWS. Bespoke informant diary mea-
sures [61] and structured interviews [54] have also been
used with some preliminary evidence of validity in PWS.
Anxiety symptoms and behaviors in PWS
Definition
Anxiety is common in PWS and is characterized by ex-
cessive worry, and tension often related, but not limited
to, schedules/routines, food planning or food security, or
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persons or items of special interest (e.g., teachers, care-
givers, pets). Concerns about the possibility of change in
these areas are often a trigger for anxiety in PWS.
Anxiety symptoms in PWS can overlap with Generalized
Anxiety Disorder (GAD) but also have unique features (e.g.,
significant worry about food planning/security and items/
people of special interest) that are not fully captured using
definitions based on the Diagnostic and Statistical Manual
of Mental Disorders (DSM-5) [62].
Description
Parents and clinicians have observed that individuals
with PWS may exhibit significant anxiety in both food
and non-food-related situations as well as during times
of transition and change of routine [57, 63]. However,
some studies do not appear to capture the extent of anx-
iety in the PWS population [64, 65], likely due to chal-
lenges of defining and measuring anxiety. Other studies
have found moderate to high levels of anxiety in PWS
samples [18, 39, 40]. Einfeld et al. [40] found that 43% of
individuals with PWS assessed with the Developmental
Behavior Checklist (DBC) had significant levels of anx-
iety. A recent study, Feighan et al. [18], found that 37%
of participants with PWS were diagnosed with anxiety
(29% of adolescents, 43% of adults), and that anxiety was
the most common psychiatric diagnosis in adolescents
and adults. Another recent publication examining care-
giver preferences for PWS treatment revealed that care-
givers rated anxiety as one of their top 2 targets for
PWS treatment [39], underscoring the negative impact
of anxiety in this population. Finally, a 2018 review of
data from the PWS Global Patient Registry [66] found
that anxiety symptoms are reported by caregivers to be a
significant problem for 48% of the sample of individuals
with PWS ages 10 and above [67].
The prevalence of anxiety symptoms in PWS appears
to be similar between males and females but higher in
individuals with the UPD genetic subtype of PWS
compared to the deletion subtype (73% vs. 32%) accord-
ing to reports of those caring for individuals with PWS
[67, 68]. Studies assessing age of onset of anxiety in
PWS have not been conducted to date; however, clinical
observations suggest that many individuals with PWS
struggle with anxiety starting around preschool to school
age (3–6 years) with peak anxiety symptoms generally
occurring during adolescence/early adulthood [66, 69].
Observable behaviors
The Diagnostic Manual–Intellectual Disablity-2 (DM-
ID-2) [70] speaks to the importance of highlighting the
behavioral equivalents of anxiety in the assessment of in-
dividuals with intellectual disability and limiting reliance
on cognitive and more subjective criteria. Although
overt behaviors of anxiety may vary in intensity among
individuals with PWS, there is a constellation of explicit
behaviors that appear to represent anxiety symptoms
commonly expressed in individuals with PWS. These
include repetitive questioning especially related to
schedules, food and people, pacing, loud and/or fast talk-
ing, excessive body and hand movements, trembling,
and checking behaviors (e.g., checking on people of par-
ticular interest and schedules). In addition, individuals
with PWS who are more verbal will frequently express
many different worries and feelings of being “stressed”
or overwhelmed. It should be noted that there is overlap
between anxiety behaviors and compulsive behaviors in
PWS as described in the section below.
Assessment of the behavior
There is no validated standard for measuring anxiety in
PWS. Previous research has reviewed tools for measuring
anxiety in individuals with intellectual disability via self-
report and observer-reported methods [71]. Although
some of these measures could be useful in describing anx-
iety symptoms in PWS, for example, Glasgow Anxiety
Scale (GAS-ID) [72] and Anxiety, Depression and Mood
Scale (ADAMS) [73], available measures do not appear to
fully capture the unique and important manifestations of
anxiety in PWS, such as excessive worry about food plan-
ning/food security and items/people of special interest.
Additionally, given challenges with insight and cognitive
difficulties in PWS (e.g., concrete thinking, short term/
working memory difficulties), it can be difficult to accur-
ately assess anxiety in this population especially using self-
report assessment tools. As noted in the DM-ID2, anxiety
symptoms in those with intellectual disability can go
undetected by others, and individuals with intellectual
disability often do not report symptoms of anxiety [70].
Given these reporting difficulties, caregiver/observer-re-
ported assessments of anxiety are recommended. Previous
research and clinical trials have employed the (C)YBOCS
[4] to assess anxiety in PWS. Although useful, this meas-
ure does not appear to fully capture the range of anxiety
symptoms in PWS as it focuses almost exclusively on ob-
sessive thoughts and compulsive behaviors. In response to
the lack of effective tools to measure the unique anxiety
symptoms and behaviors in PWS, a new measure specific
to assessing anxiety and distress in PWS is currently being
piloted. The Prader-Willi Syndrome Anxiety and Distress
Questionnaire (PADQ) is a 20-item caregiver-rated meas-
ure that assesses common indices of anxiety and distress
in PWS. The PADQ is currently being used as a secondary
outcome measure in phase 3 clinical trial in PWS.
Obsessive compulsive behaviors in PWS
Definition
Obsessive-compulsive behaviors (OCB) in PWS are
defined as repetitive, ritualistic behaviors that include
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collecting, storing/hoarding items, insistence on rou-
tines, and “sameness”. Other OCB that are common in
PWS are “needing to know, ask or tell” about certain in-
formation and distress when this behavior is prevented
[12, 13, 74–77].
Description
Anxiety in PWS is often discussed within the context of
obsessive compulsive behaviors. Previous studies have
found relatively high rates of OC-type symptoms in indi-
viduals with PWS with 37–58% having symptoms such
as those described above [13]. In a small study, State
et al. [76] also found high rates of OC symptoms and
concluded that OC symptoms are prominent in the
PWS behavioral phenotype. However, in a longitudinal
follow-up of over 250 people with PWS, Dykens and
Roof [69] found that only 8% of their sample met full
DSM-5 criteria [62] for diagnosis of obsessive compul-
sive disorder (OCD). Many of the repetitive rituals
participants with PWS engaged in did not meet the
standards for performing behaviors related to obsessive
thoughts and fears (illness, germs, cleanliness). Ho and
Dimitropoulos [78] also found that the obsessions in
PWS often did not map onto the typical preoccupations
in OCD such as worries about germs, contamination,
religion, or others being harmed. One of the most
predominant OC behaviors in PWS is repetitive ques-
tioning, which may be related to resistance to change.
For families, this behavior can be a source of consider-
able day-to-day frustration, requiring active behavioral
management strategies [79]. Clinical observations and
several studies suggest that for many individuals with
PWS the OC behaviors may bring enjoyment and are
soothing in nature, which is different from what is ob-
served in OCD [80–82]. Additionally, the Diagnostic
Manual-Intellectual Disability-2 [70] notes that for many
individuals with intellectual disability including PWS,
obsessive and compulsive behaviors often do not cause
clinically significant distress for the person, although ag-
gressive behaviors may occur if the person is prevented
from engaging in the behavior, which is different from
classic OCD. Differences between PWS-associated OC
behaviors and classic OCD are also supported by neuro-
imaging studies, which found some similarities but also
differences in cerebral circuitry activation in PWS com-
pared to classic OCD [83]. Another principal difference
is that in DSM-5 OCD definition, the symptoms are
“ego-dystonic,” that is the person has insight that their
thinking is irrational but cannot stop the thought or
behavior. In most cases of OC behaviors in individuals
with PWS, this insight is not present.
There is limited data on age of onset, frequency, or
possible genetic subtype differences in OC symptoms in
PWS. Clinical observations and parent reports suggest
that many individuals with PWS struggle with OC symp-
toms starting around age 3 [15]. Higher rates of compul-
sive behavior have also been reported among 2–3 year
olds with PWS compared to typically developing chil-
dren and young children with Down syndrome [15]. The
research on differences in OC symptoms among PWS
genetic subtypes is inconclusive, with one study finding
that overall OC behaviors were higher in the PWS
del subgroup, whereas individuals with PWS UPD
tended to have higher rates of OC behaviors that
mimic those commonly observed in autism spectrum
disorder (ASD) [84].
Observable behaviors
Obsessive compulsive behaviors in PWS vary in intensity
and scope. However, as described above, there is a con-
stellation of behaviors that are common in this popula-
tion, including insistence on “sameness” in certain
routines and need to know/tell/ask, collecting items of
interest/“hoarding,” checking behaviors (e.g., checking
on collected items of interest), and repetitive rewriting,
arranging, and rearranging.
Assessment of the behavior
Previous research and clinical trials in PWS have
employed the Children’s Yale Brown Obsessive Compul-
sive Scale [4, 85] to assess OC behaviors. The CY-BOCS
is a well-validated frequently used measure of OCD but
includes some items that are not pertinent to PWS.
Although helpful in describing some of the salient OC
symptoms in PWS, the CY-BOCS does not capture the




Rigidity in PWS is defined as ardent inflexibility with re-
spect to certain routines, concepts, or ways of thinking
with vigorous resistance to change. Rigidity can also be
characterized as “black & white thinking” and a resist-
ance to considering information or evidence that might
conflict with the rigidly held belief. People with PWS
can demonstrate both cognitive and behavioral rigidity.
Description
Parents and clinical experts report that people with PWS
often have rigid thinking styles and behaviors that
interfere with daily functioning. Individuals with PWS
commonly show a strong resistance to change [17]. This
difficulty with change of routine and inflexibility in PWS
may be linked to a cognitive deficit in task switching [56,
57]. Task switching requires being able to move from
one task to a different task in a timely manner, an area
of difficulty for individuals with PWS [56, 86].
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Studies assessing age of onset of rigidity behaviors in
PWS have not been conducted to date. However, clinical
observations suggest that many individuals with PWS
exhibit behaviors reflecting resistance to change and in-
flexibility at a young age, generally before starting
school. Dykens et al. [87] found that compulsivity and
insistence on sameness in routines or events were seen
in 76–100% of the participants with PWS (4–21 years).
Little is known about the variation of these behaviors
over time, gender, or genetic subtype differences. It is
notable that although individuals with PWS have a range
of intellectual functioning from moderate intellectual
disability (ID) to normal IQ (with some learning chal-
lenges), the symptoms of rigidity in PWS are seen across
the spectrum of intellectual function in PWS, not just in
those with lower (or higher) IQ levels. Clinically, these
behaviors have a significant impact on adaptive function-
ing and are among some of the most difficult behaviors
for parents to manage.
Observable behaviors
Overt behaviors that appear to reflect behavioral rigidity
in PWS can include needing to have things done a cer-
tain way, including in a particular order, time, or place;
difficulty with changes in the schedule or routine; and
difficulty transitioning from one activity to another (e.g.,
brother must always sit in the seat behind the driver,
hair must be worn a certain way every day, refusal to
take medication if not given the right way). Rigidity can
be observed by the person with PWS getting stuck on a
certain thought or idea and excessive talking about that
topic. Additional characteristics include inflexibility in
beliefs and difficulty considering a new perspective or
topic even when presented with conflicting information
(e.g., only females can be teachers but their teacher is
male). Another common observable behavior reflecting
rigidity in PWS is significant distress and protest when
the rigid behaviors, thoughts, or beliefs are challenged.
Additionally, protest and distress behaviors in PWS are
often seen when the person with PWS expects some-
thing that then does not happen.
Assessment of the behavior
Commonly used behavior scales (e.g., CY-BOCS, Repeti-
tive Behavior Scale-Revised- RBS-R) do not specifically
focus on rigidity. Two domains of the RBS-R do assess
needs for sameness and compulsivity in those with
autism spectrum disorder (ASD) or ID yet are not spe-
cifically tailored to PWS. Some of the rigid behaviors
seen in PWS could be captured on the CY-BOCS, but
the instrument does not adequately capture the majority
of these behaviors and does not focus on cognitive rigidity.
The Montefiore-Einstein Rigidity Scale (MERS-PWS)
is currently being developed to capture the above
described rigidity characteristic of PWS. The MERS-
PWS scale measures 3 domains that reflect rigidity: be-
havioral rigidity, cognitive rigidity, and a protest domain.
The MERS-PWS is currently being tested as a secondary
outcome measure in a clinical trial examining challen-
ging behaviors in adolescents and young adults with
PWS.
Social cognition deficits in PWS
Definition
Individuals with PWS display significant difficulties re-
lating to others, especially peers. The social difficulties
seen in PWS are characterized by challenges with recip-
rocal social communication, recognizing others’ emo-
tions, empathy, and accurate interpretation of social
cues. Social skills challenges in PWS can overlap with
those observed in ASD and are influenced by genetic
subtype.
Description
Individuals with PWS struggle with reciprocal social
communication and with recognizing emotions in
others, especially negative emotions such as sadness,
anger, and fear [88]. Related to this, individuals with
PWS have difficulty accurately processing faces [21, 89],
interpreting emotional valence in faces, being aware of
other’s personal space, and show significant develop-
mental delay in “theory of mind” tasks [50, 89–91]. In a
recent study, Dykens et al. [88] found that individuals
with PWS also have difficulties with accurately perceiv-
ing the intentions of others. The above social difficulties
could be due to differences in the way individuals with
PWS process incoming information, which could impact
on social skills. Interestingly, a physiological basis for
these deficits is likely, with genetic subtype differences
evident in several studies. Individuals with the uniparen-
tal disomy [UPD] or imprinting defect [ID] genetic sub-
types tend to have more difficulty with social
communication and are more likely to be diagnosed with
ASD; however, all genetic subtypes of PWS (deletion,
UPD, ID) show social challenges [20, 89]. To date, no
studies have found significant gender differences in so-
cial skills challenges in PWS.
Although there is overlap between the social difficul-
ties seen in PWS and those observed in ASD, the preva-
lence and nature of ASD in PWS has been the subject of
some debate among clinicians and researchers. Estimates
of ASD in people with PWS has been as high as 41%
[92]; however, Dykens et al. [87] used multimodal forms
of assessment including direct assessments of the person
with PWS and an expert clinical panel and found a rate
of ASD diagnosis of just 12.3%. The majority of those
meeting ASD criteria having the UPD genetic subtype.
The authors suggested that high rates of ASD in
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previous studies were based solely on parent-reported
screening questionnaires and thus may have overesti-
mated rates of ASD diagnosis. It should be noted,
however, that although most of the children with PWS
assessed in the Dykens et al. [87] study did not meet cri-
teria for ASD, a large majority had some level of social
skill difficulties, especially in the area of reciprocal social
interactions.
Observable behaviors
Observable behaviors that reflect the social skills chal-
lenges in PWS can manifest as lack of or minimal recipro-
cal conversation. The person with PWS typically focuses
the conversation on a narrow range of topics they are in-
terested in, with repetitive features in the conversation.
People with PWS may tend to play with younger children
and struggle more with peers. Difficulty in maintaining
personal space (e.g., standing too close) is also common
[89]. Social cognitive difficulties have been shown in chil-
dren as young as 3 years old [93]. Older children and
adults with PWS may behave in ways that reflect feelings
of being easily slighted; they may be quick to become frus-
trated or angry and take things personally. People with
PWS often have difficulty modifying their social behavior
to fit changing situations as they arise. Temper outbursts,
difficulties with routine change, and ritualistic and repeti-
tive behaviors, as mentioned above, are common in PWS
and present unique challenges in the social arena.
Assessment of the behaviors
Currently, there are no measures that are specific to
assess social skills challenges in PWS. However, some
studies exploring social challenges in PWS have
employed the Social Responsiveness Scale (SRS) and the
Social Competence Inventory [94], which are parent-
rated inventories [89]. These are well-validated measures
to assess social challenges in those with ASD or ID.
Other studies have used emotion recognition tasks or vi-
gnettes to assess social perceptions. Some of the social
challenges seen in PWS are captured by these measures,
but they do not adequately assess the breadth of unique
social challenges seen in PWS. A combination of parent,
clinician, and teacher rating scales, in addition to direct
patient measures (e.g., face/emotion tasks), may be
necessary to fully capture the nature of social skills chal-
lenges in PWS. Tools like the ADOS-2 [95] and other
clinician-rated assessments are recommended especially
when assessing for ASD. Relying on parent assessments
only may give an incomplete picture of the social skills
deficits observed in PWS [87].
Overlap of PWS behavioral symptoms and features
As is apparent from the above descriptions, there can be
significant overlap of features among the various behavioral
characteristics in PWS (Fig. 1). It may not be feasible to
tease apart these features as many individuals with PWS
struggle with multiple behavioral challenges simultaneously.
As an example, the anxiety, OC behaviors, rigidity, and
temper outbursts observed in PWS appear to have signifi-
cant overlap. One theory is that similar psychological or
physiological phenomenon and/or cognitive mechanisms,
such as difficulties with task switching or emotion regula-
tion, may underlie these behavioral challenges. However,
further research is needed to advance our understanding of
the possible mechanisms underlying these key behavioral
features in PWS. Overlap of symptoms in mental health
and behavioral disorders can be seen in the general popula-
tion as well, for example, in anxiety and depressive mood
disorders [96]. This overlap of symptoms and behaviors
across different mental health conditions and features may
occur due to universal dimensions of distress or negative
affect, as well as to shared genetic and neurobiological
aspects of these mental health conditions. This is likely a
factor in PWS as well. However, in PWS, it may not be
possible to separate out aspects of each of the behavioral
challenges unless and until we have effective treatments for
that feature. Additionally, one treatment in PWS may
address multiple behavioral features seen in the syndrome
related to overlapping neurobiological mechanisms and/or
genetic factors.
Conclusions and limitations
The primary aim of this paper is to review the current
knowledge base regarding the defining features of the
behavioral phenotype in PWS and provide consensus
definitions of these behavioral features based on the
work of the PWS-CTC Behavior Outcomes Working
Group. Developing a unified understanding of the PWS
behavioral phenotype is important as interventions and
Fig. 1 Key interrelated behavioral features of PWS
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treatments for PWS are moving forward, and the
behaviors reviewed in this paper are currently or likely
soon to be targets of treatment studies. This paper also
highlighted some of the assessment tools that are cur-
rently available and under development, which may be
useful in measuring these features in PWS. Although the
current paper discusses the use of several measurement
tools, it was beyond the scope of this paper to provide a
complete assessment of available behavioral assessment
tools and their potential utility in PWS. This paper rep-
resents only an initial foray into this area. Future studies
are needed to determine if existing measures for the
assessment of behavioral challenges in individuals with
intellectual disability can be validated for use in PWS or
whether new PWS-specific assessments are needed. Fur-
ther work on the utility of advancing more appropriate
measures for PWS will be an ongoing focus for the
PWS-CTC as well as for the field as a whole.
PWS patient vignettes
The following are PWS patient vignettes to highlight the
behavioral features discussed in this paper. These
vignettes are not based on any one patient with PWS
but rather a combination of different behaviors observed
by clinicians with experience working with individuals
with PWS.
Feature: hyperphagia
1. B. is an 18-year-old male with PWS living at home
with parents and sister. He admits he is hungry “all
the time” but would not admit to taking food
around the house or at school. He has taken bolt
cutters from the garage to break the locks on the
pantry and has also used a screwdriver to take the
hinges off locked cabinets to try to get at food. He
has convinced classmates that he did not have a
lunch after he ate it on the morning bus ride to
school. He talks and thinks about food constantly
but denies eating food when his mom finds
wrappers stuffed in his sneakers. He is clever and
fast when it comes to obtaining food; he once stole
more than 200 dollars from classmates during a
play rehearsal to buy food from a convenience store.
Because he is so friendly and social, none of the kids
thought he could have done it. They often give him
snacks and other food, because he asks “so nicely”
even though they know he should not have it.
2. J. is a 10-year-old girl with PWS who was at her
brother’s baseball game, sitting in the stands with
her mother. When her doll fell under the bleachers,
her mother let her go down and get it since she felt
she could have “eyes on her” the entire time. As she
returned from getting her doll, she reached into a
backpack that was near the coaching bench and
quickly took something out and poured it in her
mouth, swallowing hard. Her mother ran to her
and asked her what she ate but she put her hands
over her mouth and would not talk. Her mother
raised her voice in tears asking, “What did you get?”
Everyone at the ballpark was looking at them. J
never admitted to what she ate but had food around
her mouth and hands.
Feature: temper outbursts
1. K is a 22-year-old male with PWS living at home
with parents and sister. He has aged out of school
services and is now waiting for vocational services.
He began having temper tantrums at age 8, and
they have gotten progressively worse, with broken
furniture, scared family members, and calls to
police. For example, K became upset when a
sporting event was rained out and he had to leave
the field unexpectedly. He became more agitated on
the drive home, cursing and asking “why” he had to
go home. His parents’ explanations about lightning
and possible injury or death could not dissuade him
from the “unfairness” of the situation. He came
home, went to his room and within minutes had
broken a lamp, his glasses, and ripped his shirt. He
came out and threatened his mom and tried to hit
her with a book. Dad intervened and finally had to
sit on his 150-lb son to keep him from injuring
himself or others. Police have been called by
neighbors and his own parents, but besides taking
him to the station or patrol car for a “scared
straight moment,” they have no answers. He is
usually quite tearful and remorseful after these
tantrums blow over but admits he cannot control
them when they are happening.
2. J is a 10-year-old girl living with PWS. While at
school 1 day shortly after recess started, one of the
teachers noticed J laying on the ground yelling,
swatting, and biting anyone close to her. Then, a
loud pitched scream came from her that stopped
the playground. J then got up and started running,
knocking anyone and anything in her path. She then
curled up in a ball on the other side of the field and
the teachers told everyone to give J space. She
finally calmed and then sat picking handfuls of
grass. The vice principal came out to talk to J who
at first would not speak. As the principal talked
quietly to her, J. calmed down but seemed not to
recall the event. When asked how she was feeling,
she said, “Fine.” She then got up to walk back to
her classroom. The principal noted that these
episodes happen frequently.
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Feature: obsessive compulsive behaviors
A is a 16-year-old girl with PWS who lives at home with
her parents, attends a local high school, and receives
special education services. Her father reports that A col-
lects and hoards hundreds of rubber gloves and spends
countless hours sorting, piling, and rolling them into
tight balls and then puts them in bins. She does not use
the gloves. She does this activity for hours after school,
and if her father walks into her room, she must check
the sole of his shoes and pockets to make sure that none
of her gloves have been inadvertently “picked up”. If her
parents try to limit this activity or keep her from obtain-
ing more gloves, she becomes hysterical and sometimes
aggressive. She even insists on taking them on family
trips and recently to her grandfather’s funeral.
Feature: anxiety symptoms
M is an 11-year-old girl with PWS living with her par-
ents and three siblings. She spends hours a day confirm-
ing the daily schedule, asking many questions about who
will carry out daily care and academic activities, and
needs to check in constantly with mom and a full-time
care assistant. She becomes tearful if her mom reminds
her that her schedule is the same every day and the same
people will be helping her. She asks, “but what if it’s
not?” What if’s rule her life, and M shuts down if care-
givers try to discuss this with her. If they persist in this
M.’s behaviors escalate to crying and yelling. M asks
more than 300 questions a day and does not trust her
teacher, aides, and other school staff to help. The school
had to call mom every day several times/day because of
this. Her anxiety behaviors at school became unmanage-
able and her mom has chosen to homeschool her now.
M is on more than 3 psychiatric medications, which
have helped “take the edge off,” but have not reduced
her anxiety to allow for increased functioning for M.
Feature: rigidity
P is a 23-year-old male living with his parents. He went
to a local school and graduated with a regular diploma,
fulfilling all state requirements, and he yearns for a “real
job”. He has been unable to keep employment because
of his rigid behaviors. P feels that tasks should be
completed a certain way and is taken to arguing with
coworkers and bosses when he feels they are “wrong”.
He once was fired after arguing with a customer about
which dog food is best. P tried unsuccessfully to con-
vince the customer that the food they wanted was not as
good for their dog as another brand. The customer tried
to be good-natured, but eventually asked for a manager.
P then tried to convince the manager “that no one
knows more about dogs than me”. He has many strongly
held beliefs on everything (from best pizza in Baltimore
to worst gorilla exhibit in the USA) and spends a great
deal of time trying to convince others that he is right.
These beliefs often are based on things he has read and
facts that he believes. The preferences and opinions of
others do not deter him of his mission that he is right
and that others are wrong. His parents are worried that
he won’t be able to ever maintain employment or social
connections because he cannot be dissuaded and that he
cannot avoid arguing with and offending others.
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